Selected by Scripps Research, Fitbit is first
wearable brand in historic precision medicine study
Fitbit (NYSE:FIT), the leading global wearables brand, and the
National Institutes of Health (NIH) today launched the Fitbit
Bring-Your-Own-Device (BYOD) project, the first digital health
technology initiative for the All of Us Research Program. Fitbit
users currently enrolled in the program can now choose to sync
their Fitbit accounts to help researchers unlock deeper insights
into the relationships between health indicators such as physical
activity, heart rate, sleep and health outcomes. By consenting to
sync their data with All of Us, Fitbit users have the opportunity
to contribute to one of the world’s largest precision medicine
studies and help build one of the most diverse data sets for
scientific research. Fitbit is the first wearable to be included in
the program.
Launched nationally in May 2018, All of Us seeks to enroll one
million or more participants, with the goal of improving the
ability to prevent and treat disease based on individual
differences in lifestyle, environment and genetics. Participants
will be invited to share different types of health information over
time through surveys, electronic health records, physical
measurements, biosamples and digital health technologies. Data will
be made accessible to researchers for a wide range of health
studies, with strict safeguards in place to protect participant
privacy.
“Collecting real-world, real-time data through digital
technologies will become a fundamental part of the program,” said
Eric Dishman, director of the All of Us Research Program. “This
information in combination with many other data types will give us
an unprecedented ability to better understand the impact of
lifestyle and environment on health outcomes and, ultimately,
develop better strategies for keeping people healthy in a very
precise, individualized way.”
As a national leader in research using digital health
technologies, Scripps Research is spearheading the program’s
digital health effort. In 2017, Scripps Research selected Fitbit as
the first wearable for use in the groundbreaking All of Us program,
based on the popularity and credibility of its use in
peer-validated clinical research. An analysis1 published by
the Federation of American Societies for Experimental Biology
(FASEB) Journal found that Fitbit devices are the
most commonly used tracker in biomedical research. To date, more
than 6752 published studies have used a Fitbit device and according
to a recent analysis, Fitbit is registered in ClinicalTrials.gov
studies 10 times as often than other brands.3 This includes the use
of Fitbit devices in areas such as diabetes, cardiovascular health,
oncology, mental health and post-surgery.
“This is a tremendous opportunity for Fitbit users who choose to
participate, to further contribute to one of the world’s largest
research efforts by providing information that can help pave the
way to a healthier future for all of us,” said Adam Pellegrini,
general manager, Fitbit Health Solutions. “Every day we learn more
about the potential for wearable data to inform personalized
healthcare and through All of Us, the research community will
gain an even better understanding of the role wearable data can
play in helping to prevent and treat disease.”
While Fitbit users can use their device to sync health stats
with the program, a device is not required to participate. All of
Us participants can also choose to connect their data through their
Fitbit account and manually add information such as their weight,
water intake and meals. To get started, participants can log on to
the All of Us participant portal at participant.JoinAllofUs.org and
visit the Sync Apps & Devices page. Fitbit users and others
ages 18 and up living in the United States interested in enrolling
in the All of Us Research Program can learn more by visiting
www.joinallofus.org.
A second All of Us research initiative using Fitbit devices will
launch in 2019 that involves providing up to 10,000 Fitbit devices
to a diverse set of participants randomly invited to take part. The
study, which will be conducted by Scripps Research Translational
Institute, will generate a unique data set for exploring the
relationship between health indicators such as physical activity,
heart rate and sleep in conjunction with other critical health
outcomes that will be captured as part of All of Us.
Precision Medicine Initiative and All of Us are service
marks of the U.S. Department of Health & Human
Services.
About Fitbit
Fitbit helps people lead healthier, more active lives by
empowering them with data, inspiration and guidance to reach their
goals. As the leading global wearables brand, Fitbit designs
products and experiences that track and provide motivation for
everyday health and fitness. Fitbit’s diverse line of innovative
and popular products include Fitbit Charge 3™, Fitbit Alta HR™,
Fitbit Alta®, Fitbit Ace™, Fitbit Flex 2®, and Fitbit Zip® activity
trackers, as well as the Fitbit Ionic™ and Fitbit Versa™
smartwatches, Fitbit Flyer™ wireless headphones and Fitbit Aria 2™
Wi-Fi Smart Scale. Fitbit products are carried in over 39,000
retail stores and in 87 countries around the globe. Powered by one
of the world’s largest social fitness networks and databases of
health and fitness data, the Fitbit platform delivers personalized
experiences, insights and guidance through leading software and
interactive tools, including the Fitbit and Fitbit Coach apps, and
the Fitbit OS for smartwatches. Fitbit Health Solutions develops
health and wellness solutions designed to help increase engagement,
improve health outcomes, and drive a positive return for employers,
health plans and health systems.
Fitbit and the Fitbit logo are trademarks or registered
trademarks of Fitbit, Inc. in the U.S. and other countries.
Additional Fitbit trademarks can be found at
www.fitbit.com/legal/trademark-list. Third-party trademarks are the
property of their respective owners.
Connect with us on Facebook, Instagram or Twitter and share your
Fitbit experience.
Forward-Looking Statements
This press release contains forward-looking statements, within
the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, that involve risks and uncertainties
including, among other things, statements regarding future research
initiatives using Fitbit devices. These forward-looking statements
are only predictions and may differ materially from actual results
due to a variety of factors, including the effects of the highly
competitive market in which we operate, including competition from
much larger technology companies; any inability to successfully
develop and introduce new products, features, and services or
enhance existing products and services; product liability issues,
security breaches or other defects; and other factors discussed
under the heading “Risk Factors” in our most recent report on Form
10-Q filed with the Securities and Exchange Commission. All
forward-looking statements contained herein are based on
information available to us as of the date hereof and we do not
assume any obligation to update these statements as a result of new
information or future events.
1 Stephen P Wright, Scott R Collier, Tyish S Brown, and Kathryn
Sandberg. An analysis of how consumer physical activity monitors
are used in biomedical research. FASEB Journal.
https://www.fasebj.org/doi/abs/10.1096/fasebj.31.1_supplement.1020.24
2 Research Library Update. Fitabase.
https://www.fitabase.com/research-library/
3 Andre Henriksen et al. Using Fitness Trackers and Smartwatches
to Measure Physical Activity in Research: Analysis of Consumer
Wrist-Worn Wearables. Journal of Medical Internet Research.
https://www.jmir.org/2018/3/e110/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190116005260/en/
Fitbit, Inc.Jen Ralls, 415-941-0037PR@fitbit.com
Fitbit (NYSE:FIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fitbit (NYSE:FIT)
Historical Stock Chart
From Jul 2023 to Jul 2024